CNS5:Volunteer Assignments and Opportunities: Difference between revisions
| [checked revision] | [checked revision] |
No edit summary |
Author content - pending or complete - column |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br /> | To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br /> | ||
__TOC__ | |||
{| class="wikitable" style="margin:auto" | {| class="wikitable" style="margin:auto" | ||
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big> | |+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big> | ||
| Line 17: | Line 18: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS) | | | ||
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 42: | Line 44: | ||
|6/25/2023 | |6/25/2023 | ||
| | | | ||
| | |COMPLETE | ||
| | | | ||
|Laveniya Satgunaseelan (LS) | |Laveniya Satgunaseelan (LS) | ||
| Line 61: | Line 63: | ||
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]] | |[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]] | ||
|Disease | |Disease | ||
| | | | ||
| | | | ||
| | | | ||
| | | | ||
| | |||
| | |||
| | | | ||
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added | |Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added | ||
| Line 108: | Line 110: | ||
|5/3/2024 | |5/3/2024 | ||
| | | | ||
|PENDING | |PENDING - email reminder 9/4/2025 | ||
| | | | ||
|LS | |LS | ||
| Line 116: | Line 118: | ||
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]] | |[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]] | ||
|Disease | |Disease | ||
|Laveniya Satgunaseelan | |Laveniya Satgunaseelan | ||
| | | | ||
| | | | ||
| Line 171: | Line 173: | ||
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | |[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]] | ||
|Disease | |Disease | ||
| | | | ||
| | |<br /> | ||
| | |||
| | |||
| | | | ||
|LS | |LS | ||
| Line 193: | Line 195: | ||
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]] | |[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]] | ||
|Disease | |Disease | ||
|Wahab Khan | |||
|15/04/2025 | |||
| | | | ||
| | |PENDING - email reminder 9/4/2025 | ||
| | | | ||
|LS | |LS | ||
| Line 336: | Line 338: | ||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]] | |[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]] | ||
|Disease | |Disease | ||
|Laveniya Satgunaseelan | |||
|9/11/2024 | |||
| | | | ||
| | |COMPLETE | ||
| | |8/7/2025 | ||
| | |LS | ||
| | |LS | ||
| | |Used for testing 9/2024 somatic template | ||
|- | |- | ||
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]] | |[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]] | ||
| Line 532: | Line 534: | ||
| | | | ||
|- | |- | ||
|CHAPTER 3 (CHOROID PLEXUS TUMOURS) | | | ||
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 585: | Line 588: | ||
| | | | ||
|- | |- | ||
|CHAPTER 4 (EMBRYONAL TUMOURS) | | | ||
====CHAPTER 4 (EMBRYONAL TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 737: | Line 741: | ||
| | | | ||
|- | |- | ||
|CHAPTER 5 (PINEAL TUMOURS) | | | ||
====CHAPTER 5 (PINEAL TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 823: | Line 828: | ||
| | | | ||
|- | |- | ||
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS) | | | ||
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 931: | Line 937: | ||
| | | | ||
|- | |- | ||
|CHAPTER 7 (MENINGIOMA) | | | ||
====CHAPTER 7 (MENINGIOMA)==== | |||
| | | | ||
---- | ---- | ||
| Line 962: | Line 969: | ||
| | | | ||
|- | |- | ||
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS) | | | ||
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)==== | |||
| | | | ||
---- | ---- | ||
| Line 1,114: | Line 1,122: | ||
| | | | ||
|- | |- | ||
|CHAPTER 9 (MELANOCYTIC TUMOURS) | | | ||
====CHAPTER 9 (MELANOCYTIC TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 1,156: | Line 1,165: | ||
| | | | ||
|- | |- | ||
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS) | | | ||
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)==== | |||
| | | | ||
---- | ---- | ||
| Line 1,341: | Line 1,351: | ||
| | | | ||
|- | |- | ||
|CHAPTER 11 (GERM CELL TUMOURS) | | | ||
====CHAPTER 11 (GERM CELL TUMOURS)==== | |||
| | | | ||
---- | ---- | ||
| Line 1,372: | Line 1,383: | ||
| | | | ||
|- | |- | ||
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION | | | ||
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION==== | |||
| | | | ||
---- | ---- | ||
| Line 1,458: | Line 1,470: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
|CHAPTER 13 (METASTASES TO THE CNS) | | | ||
====CHAPTER 13 (METASTASES TO THE CNS)==== | |||
| | | | ||
---- | ---- | ||
| Line 1,500: | Line 1,513: | ||
| | | | ||
|- | |- | ||
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS) | | | ||
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)==== | |||
| | | | ||
---- | ---- | ||